Abstract
Murexine (urocanoylcholine, [2-β-imidazol-4(5)-ylacryloyloxyethyl]trimethylammonium chloride hydrochloride) produced a contracture like acetylcholine in the frog rectus and a neuromuscular block in the rat diaphragm which was not relieved by neostigmine but was antagonized by hexamethonium. Using the foot muscle of the frog, electrical recordings showed that murexine produced a neuromuscular block and depolarized the end-plate region. These effects were similar to those seen with suxamethonium, decamethonium and acetylcholine. While murexine had the same depolarizing potency as decamethonium, it was only one-tenth as active as suxamethonium and acetylcholine. It was concluded that murexine could be classified as a “depolarizing type” of neuromuscular blocking agent but was less potent than suxamethonium.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BELL P. M. Stimulator control to provide single shocks alternately to nerve and muscle with faradic stimulation of the nerve at predetermined intervals. J Physiol. 1957 Jun 18;137(1):1–2P. [PubMed] [Google Scholar]
- ERSPAMER V., GLASSER A. The pharmacological actions of murexine (urocanylcholine). Br J Pharmacol Chemother. 1957 Jun;12(2):176–184. doi: 10.1111/j.1476-5381.1957.tb00117.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NICHOLLS J. G., QUILLIAM J. P. The mechanism of action of paraldehyde and methylpentynol on neuromuscular transmission in the frog. Br J Pharmacol Chemother. 1956 Jun;11(2):151–155. doi: 10.1111/j.1476-5381.1956.tb01045.x. [DOI] [PMC free article] [PubMed] [Google Scholar]